It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PFE’s FA Score shows that 1 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PFE’s TA Score shows that 7 TA indicator(s) are bullish while SCLX’s TA Score has 2 bullish TA indicator(s).
PFE (@Pharmaceuticals: Major) experienced а +2.28% price change this week, while SCLX (@Pharmaceuticals: Major) price change was +15.01% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.35%. For the same industry, the average monthly price growth was +5.72%, and the average quarterly price growth was +12.95%.
PFE is expected to report earnings on Nov 04, 2025.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
PFE | SCLX | PFE / SCLX | |
Capitalization | 143B | 102M | 140,196% |
EBITDA | N/A | -66.58M | - |
Gain YTD | -0.141 | 21.147 | -1% |
P/E Ratio | 13.30 | N/A | - |
Revenue | N/A | 50.7M | - |
Total Cash | N/A | 5.8M | - |
Total Debt | 61.3B | 41.5M | 147,711% |
PFE | ||
---|---|---|
OUTLOOK RATING 1..100 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 76 | |
PRICE GROWTH RATING 1..100 | 52 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PFE | SCLX | |
---|---|---|
RSI ODDS (%) | 5 days ago44% | 3 days ago41% |
Stochastic ODDS (%) | 3 days ago55% | 3 days ago51% |
Momentum ODDS (%) | 3 days ago49% | N/A |
MACD ODDS (%) | 3 days ago48% | N/A |
TrendWeek ODDS (%) | 3 days ago58% | 3 days ago46% |
TrendMonth ODDS (%) | 3 days ago53% | 3 days ago35% |
Advances ODDS (%) | 5 days ago57% | 5 days ago72% |
Declines ODDS (%) | 18 days ago60% | N/A |
BollingerBands ODDS (%) | 3 days ago51% | 3 days ago40% |
Aroon ODDS (%) | 3 days ago58% | 3 days ago25% |
1 Day | |||
---|---|---|---|
CRYPTO / NAME | Price $ | Chg $ | Chg % |
TLM.X | 0.005018 | 0.000271 | +5.71% |
Alien Worlds cryptocurrency | |||
WING.X | 0.171081 | 0.007146 | +4.36% |
Wing Finance cryptocurrency | |||
LTC.X | 120.946870 | 1.899750 | +1.60% |
Litecoin cryptocurrency | |||
OM.X | 0.257247 | 0.001886 | +0.74% |
MANTRA cryptocurrency | |||
BAL.X | 1.334930 | -0.006007 | -0.45% |
Balancer cryptocurrency |
A.I.dvisor indicates that over the last year, PFE has been loosely correlated with MRK. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then MRK could also see price increases.
A.I.dvisor tells us that SCLX and CSWYF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and CSWYF's prices will move in lockstep.
Ticker / NAME | Correlation To SCLX | 1D Price Change % | ||
---|---|---|---|---|
SCLX | 100% | +4.09% | ||
CSWYF - SCLX | 24% Poorly correlated | N/A | ||
BIIB - SCLX | 21% Poorly correlated | +2.71% | ||
AMRN - SCLX | 21% Poorly correlated | +4.06% | ||
PFE - SCLX | 14% Poorly correlated | +0.12% | ||
ABBV - SCLX | 12% Poorly correlated | +0.98% | ||
More |